Shell Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Buy |
|
|||||
|
2025
Q1 | $1.53M | Sell |
|
|||||
|
2024
Q4 | $1.41M | Sell |
|
|||||
|
2024
Q3 | $1.7M | Buy |
|
|||||
|
2024
Q1 | $722K | Sell |
|
|||||
|
2023
Q4 | $728K | Sell |
|
|||||
|
2023
Q3 | $856K | Sell |
|
|||||
|
2023
Q2 | $932K | Sell |
|
|||||
|
2023
Q1 | $1M | Buy |
|
|||||
|
2022
Q4 | $1.07M | Sell |
|
|||||
|
2022
Q3 | $973K | Sell |
|
|||||
|
2022
Q2 | $986K | Buy |
|
|||||
|
2022
Q1 | $1M | Buy |
|
|||||
|
2021
Q4 | $985K | Buy |
|
|||||
|
2021
Q3 | $709K | Sell |
|
|||||
|
2021
Q2 | $666K | Buy |
|
|||||
|
2021
Q1 | $419K | Buy |
|
|||||
|
2020
Q4 | $366K | Sell |
|
|||||
|
2020
Q3 | $418K | Sell |
|
|||||
|
2020
Q2 | $472K | Sell |
|
|||||
|
2020
Q1 | $490K | Buy |
|
|||||
|
2019
Q4 | $507K | Sell |
|
|||||
|
2019
Q3 | $458K | Hold |
|
|||||
|
2019
Q2 | $413K | Buy |
|
|||||
|
2019
Q1 | $370K | Hold |
|
|||||
|
2018
Q4 | $289K | Sell |
|
|||||
|
2018
Q3 | $518K | Sell |
|
|||||
|
2018
Q2 | $971K | Sell |
|
|||||
|
2018
Q1 | $1.42M | Sell |
|
|||||
|
2017
Q4 | $3.02M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $227K | Hold |
|
|||||
|
2016
Q2 | $186K | Sell |
|
|||||
|
2016
Q1 | $233K | Buy |
|
|||||
|
2015
Q4 | $331K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $725K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $405K | Sell |
|
|||||
|
2013
Q3 | $851K | Hold |
|
|||||
|
2013
Q2 | $412K | Buy |
|